1 Ensuring medicines save lives: Facilitating access Defeating Malaria Together Jaya Banerji Director, Communications & Advocacy MMV.

Slides:

Advertisements

Similar presentations

1 Policy options to address access to chronic disease medicines Dr. Richard Laing Ms. Alexandra Cameron Department of Essential Medicines and Pharmaceutical.

Advertisements

Understanding the Antimalarials Market in Uganda Rosette Mutambi, HEPS Uganda Martin Auton, Health Action International, The Netherlands ASTMH, December.

Lessons Learned in Social Protection in health Group 8.

Student: Song Lijie Advisor: Prashant Yadav Santiago Kraiselburd

Private Sector Malaria Case Management: Experience from 7 years of implementation in Cambodia Presented by Dr. Socheat, Director of CNM RBM Working Group.

Presentation to the 2014 International AIDS Conference

APPMG World Malaria Day Event, 2013 Invest in The Future: Defeat Malaria Kolawole Maxwell, Malaria Consortium Nigeria Country Director.

RBM Case Management Working Group Meeting, Geneva 8-9 th July |1 | Dr Wilson Were CAH/CIS Community Case Management of Malaria Child Adolescent.

Country Ownership for Reproductive Health; An NGO perspectiveSLIDE 1 “ACCESS FOR ALL: SUPPLYING A NEW DECADE FOR REPRODUCTIVE HEALTH ” Country Ownership.

KINGDOM OF CAMBODIA Ministry of Health National Center for Parasitology, Entomology and Malaria Control CNM.

Technical Advisory Group meeting, WHO/WPRO

Supply Chains Management for Pharmacy

Supporting community action on AIDS in developing countries Liza Tong Programme Manager International HIV/AIDS Alliance “Whose Value Counts”: A community.

World Health Organization

Improving Access to ACTs Through Licensed Chemical Sellers in Ghana David Ofori-Adjei 1, Sylvester Segbaya 2, Kwadwo Koram 1, Kwame Adogboba 3, and Nana.

World Health Organization

Unit 8 Supply Chain. Objectives 1.Describe the special nature of health care commodities due to the need for provider advice and counseling 2.Describe.

Access to Medicines: Antimalarials WHO/UNICEF Technical Briefing Seminar 10 October 2007 Silvia Schwarte Supply Chain Management Global Malaria Programme.

Update on work on the Global ACT Subsidy Roll Back Malaria Global ACT Subsidy Task Force Presentation to RBM Board 10 May 2007.

1 Towards the future: medicines and the elimination of malaria Defeating Malaria Together Timothy N.C. Wells PhD ScD Chief Scientific Officer MMV.

COUNTRY ACTION: SUSTAINABLE INVESTMENT STOP TB PARTNERSHIP FORUM STOP TB PARTNERSHIP FORUM 24TH-26TH MARCH TH-26TH MARCH 2004 BY BY MRS NENADI USMAN.

Downloaded from Accelerate scaling up of TB/HIV activities in Tanzania Dr. N.G.SIMKOKO WHO/NTLP - Tanzania.

Realising a lasting jump in health care performance 28 January 2009 Caroline Figuères, managing director WB ICT sector Week.

Global ACT Subsidy Role of RBM Partnership Dr Awa Marie Coll-Seck Executive Director, RBM Partnership APPMG London July 2007.

MALARIA TRACK SESSION SUMMARIES_ICIUM 2011 TEAM MEMBERS: EVELYN ANSAH, KOJO YEBOAH-ANTWI, CHARLES EZENDUKA, DAVID OFORI-ADJEI.

Medicines Transparency Alliance01/10/2015 Availability of Medicines Anita Wagner Harvard Medical School & WHO Collaborating Center in Pharmaceutical Policy.

Immunization service delivery – immunization management prospective.

AMFm Overview and Case Management Observations RBM Case Management Working Group (CMWG)

Summary of ICIUM Chronic Care Track Prepared by: Ricardo Perez-Cuevas Veronika Wirtz David Beran.

Introduction to Elements of In-Country Drug Management with Focus on TB Drugs Jim Rankin Director, Center for Pharmaceutical Management Management Sciences.

“The causes of Anti-TB medicines shortages in EMR countries and how to avoid them in the future” Khaled Sultan Drug Management Technical Officer, STOP.

Tanzania1. 2 Tanzania Assessment Gabriel Upunda Tanzania3 DemographicsTanzania Area (sq km)945,100 Population 32,900,000 25% urban GNP per capitaUS $240.

Malaria Case management KPA conference. Presentation outline  Introduction  National malaria strategy  Case management targets  AMFm subsidy  The.

The International Health Partnership (IHP) Anna Marriott Health Policy Officer Oxfam GB.

Malaria treatment policies: the challenge, strategies and the options SOTA, Nairobi, Kenya 12 th June 2002.

ACCESS TO MEDICINES - POLICY AND ISSUES

Dr. Mwendwa Eunice Mwenesi, Tanzania Ministry of Health and Social Welfare, Presentation to the mHealth Working Group, Washington DC, December 1 st, 2011.

Issues in malaria diagnosis and treatment May 31, 2007 Jacek Skarbinski, MD Malaria Branch Centers for Disease Control and Prevention.

Bad intentions - good policies: Who wins? Case exercise and role play on drug counterfeiting in an LDC context World Bank Case Exercise – all names and.

Yemaneberhan Taddesse.  PASDEP(plan of accelerated and sustainable development for the Eradication of poverty) Poverty reduction strategy is the main.

THE REPUBLIC OF UGANDA National AIDS Conference Presentation during the 4 th Uganda AIDS partnership Forum, Munyonyo, 31 st January 2006 By James Kaboggoza-Ssembatya,

Medicines Transparency Alliance Presented by Gilles Forte Department of Essential Medicines and Health Products, WHO On behalf of WHO and HAI Technical.

World Health Organization "3 by 5" Target Treat 3 million by 2005.

Update on the Affordable Medicines Facility-malaria (AMFm) / Private Sector Co-payment Mechanism for ACTs Interagency Pharmaceutical Coordination Group.

Securing the Supply of Condoms and Other Essential Products for HIV/AIDS Programs Tony Hudgins Yasmin Chandani John Snow Research & Training Institute.

Philippe Duneton11 February 2009 Deputy Executive Secretary 5th Consultative Stakeholder Meeting UN Prequalification of Diagnostics, Medicines & Vaccines.

Strengthening SME system for national programmes moving from transmission reduction to elimination phase Cambodia.

High Level Policy Dialogue – Cambodia Towards a Strong and Sustainable Health Sector Development ( Health Strategic Plan) 24 June, 2015 Cambodia.

1 Implementing the Community strategy for primary health care: key lessons for Africa Prof. Anthony K. Mbonye Director Health Services, Ministry of Health.

ICIUM 2011 Can Accredited Drug Dispensing Outlets (ADDO) Accomplishments be Sustained in Tanzania.

WHO Prequalification of Medicines: a gateway to the global pharmaceutical market Introduction 28 June 2014, Shanghai Milan Smid.

Pediatric TB Drugs Panel

Indicators for monitoring and assessing pharmaceutical situation in countries Dr. Edelisa D. Carandang Drug Action Program (DAP) Essential Drugs and Medicines.

Expanding Regulated Private Sector Medicines Access - Experiences with Accredited Drug Dispensing Outlets Romuald Mbwasi, PhD.

Pharmaceutical Working Group Working Group on Pharmaceuticals Key Points for Advocacy and Action.

Strengthening Integration between RMNCH and HIV services Nuhu Yaqub WHO Tanzania.

ADDRESSING PHARMACEUTICAL SUPPLY CHAIN NEEDS PRESENTATION TO HEALTH DONOR GROUP MEETING 8 July 2009.

Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.

Gender, Health and Poverty: Critical Factors Beyond the Health Sector Arlette Campbell White World Bank Institute.

TECHNICAL Review: M&E Strategy and Indicators DR HARRIET KIVUMBI, PUBLIC HEALTH SPECIALIST, ACCESS-SMC.

1 Report of the AMFm Ad Hoc Committee Todd Summers, Chair Eyitayo Lambo, Vice-Chair.

MeTA Phase I: Where are we? MeTA18/06/ MeTA2 The MeTA Phase I Proposal Purpose To pilot a new multi-stakeholder approach towards increasing transparency.

Carly Koinange Share the Road Global Programme Lead UNEP.

Points of Agreement Artemisinins should be the mainstay of first-line treatment in the short-to-medium term, at least First-line treatment for uncomplicated.

Complementary Financing for the Investment Case

Aminatou Sar, seconaf, rhsc wednesday, february 1, 2017

WHO Medicines Work in Countries: The Kenya Example

Malaria Programmes and Implication on Strengthening the overall Health System Presentation by Dr Maryse Dugué RBM Partnership Secretariat, Malaria Medicines.

MMV: Origins, Mission & Vision

Global Health Technology

Presentation transcript:

1 Ensuring medicines save lives: Facilitating access Defeating Malaria Together Jaya Banerji Director, Communications & Advocacy MMV

Scientists have passed on the new medicine 2 We have to ensure it reaches the vulnerable

child dies every seconds from malaria

Getting medicines to the most vulnerable 4 …is almost as challenging as drug development!

The road to access is not smooth 5 Potholes Price Funding Availability Stockouts Hurdles Stringent regulatory and WHO approval? National registration? Supported by KOLs? Packaging Training health workers

Let’s take the example of Coartem Dispersible 6 HurdlesCoartem D Stringent regulatory approval / WHO Prequalification Yes WHO Standard Treatment Guidelines Yes Eligible for donor fundingYes National Registration35 countries User-friendly, culturally adapted packaging worked best Steps leading to acceptance

Medicines are available and affordable 7 Available: 65 million treatments for children in 18 months Affordable: $ in the public sector.

A subsidy drives prices even lower Affordable Medicines Facility for malaria (AMFm) Saving lives and delaying resistance: co-payment ensures uptake Pilot phase 2010 – 2012: so far 122 million courses of treatment ordered 97% of are fixed-dose combinations Importer price for Coartem D: $ $0.01 Ghana Madagascar Uganda Tanzania Nigeria Niger Kenya + Cambodia

THE REPUBLIC OF UGANDA Surgipharm Pilot in Uganda: key supporting evidence Align the policy: Over the Counter (OTC) Training in dispensing and use Adequate margin to maintain supply chain Community mobilisation Umbrella Brand (ACT-leaf)

Result: ACTs replace Chloroquine for the under 5s 12%

Availability in remote areas is challenging

Frequent stock-outs plague all channels

Why are they bare? – The Information Gap 13 Products A-Z Different Manufacturers Public / Private Importation Uni-directional blind push Unknown Quantities Unanalyzed Flows No view on mix

Mobile networks to the rescue SMS-for-Life allows real-life tracking of stock in pharmacies

Future: Monitored flows, nationally and at point of care 15 Products A-Z Different Manufacturers Govt Accord w/ IMS & MMV SMS for Life at POC (point of care) * IMS Import Flow Analysis * SMS for Life data flow Weekly data from POC to district HQ Weekly re- allocation of stock

MMV’s Vision Discover, develop and deliver innovative antimalarials to cure and protect the vulnerable and help ultimately eradicate this terrible disease